XBP Global (NASDAQ:XBP – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research report issued on Friday,Benzinga reports. They currently have a $5.00 target price on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 113.68% from the company’s previous close.
XBP Global Stock Up 5.9%
Shares of NASDAQ XBP opened at $2.34 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.71 and a debt-to-equity ratio of 4.12. XBP Global has a 12 month low of $2.07 and a 12 month high of $25.60. The firm has a market capitalization of $27.54 million, a PE ratio of -1.06 and a beta of -0.39. The firm has a fifty day simple moving average of $3.77 and a two-hundred day simple moving average of $5.78.
XBP Global (NASDAQ:XBP – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($2.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($2.10). The business had revenue of $197.09 million during the quarter, compared to the consensus estimate of $199.10 million. XBP Global had a return on equity of 2,609.22% and a net margin of 139.50%.
Institutional Inflows and Outflows
XBP Global Company Profile
XBP Europe Holdings, Inc provides bills, payments, and related solutions and services in France, Germany, the United Kingdom, Sweden, and internationally. The company operates through two segments, Bills & Payments and Technology. The Bills & Payments segment focuses on optimizing how bills and payments are processed by businesses of all sizes and industries. This segment also offers automation of accounts payable and accounts receivables processes and seeks to integrate buyers and suppliers, as well as engages in digital transformation business.
Featured Articles
- Five stocks we like better than XBP Global
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
Receive News & Ratings for XBP Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBP Global and related companies with MarketBeat.com's FREE daily email newsletter.
